A very large number of serious human and animal diseases such as AIDS, SARS, common cold, human and avian influenza, chickenpox, and several others are caused by viral infections. The infectious agents of these diseases are virus nanoparticles (virions) that contain DNA/RNA strands encased in a capsid protein coat and in some cases also in an outer lipid envelope. The virions are usually transmitted from the infected cases through airborne dissemination or diffusion during nosocomial transfusion of blood or body liquids. The onset of the viral infection is usually heralded by the entry of the virion's genetic material into the intracellular space followed by the uncontrollable integration with the host DNA and virus replication. Despite decades of research, virion detection, pre-emptive and post-infection anti-viral treatments and immunotherapies remain ineffective and the morbidity and mortality rates due to the associated infections remain high. I n t h i s r e p o r t , r oom-temperature, atmospheric-pressure plasma needle treatment is used to effectively minimize the adenovirus (AdV) infectivity as quantified by the dramatic reduction of its gene expression in HEK 293A primary human embryonic kidney cells studied by green fluorescent protein imaging. The AdV titer is reduced by two orders of magnitude within only 16 min of the plasma exposure. This effect is due to longer lifetimes and higher interaction efficacy of the plasma-generated reactive species in confined space exposed to the plasma rather than thermal effects commonly utilized in pathogen inactivation. This generic approach is promising for the next-generation anti-viral treatments and imunotherapies.
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